Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present CDEX Inc. (OTC: CDEX).

Full DD Report for CDEX

You must become a subscriber to view this report.


Recent News from (OTC: CDEX)

Rounds Report: Solid Biosciences Is Making A Comeback While Improving FDA Policies To Favor Nektar
Part of what you must learn is how to handle mistakes and new facts that change the odds. Life, in part, is like a poker game, wherein you have to learn to quit sometimes when holding a much-loved hand. - Charlie Munger Trading Analytics Welcome to another edition of Integrated BioSci Ro...
Source: SeekingAlpha
Date: April, 22 2018 12:27
SEC Suspension of Trading
SEC Suspension of Trading
Source: OTC Markets
Date: January, 17 2018 00:00
"New To The Street" Announces Upcoming Interviews With 6 New Clients & 5 Recurring Clients
NEW YORK, NY--(Marketwired - Aug 24, 2015) - " New To The Street " announces with excitement its current line-up for the taping of their newest show, set for September 10, 2015 in their state of the art studios in NYC. This taping will preview for the first time: Seen on Screen TV, In...
Source: Marketwired
Date: August, 24 2015 16:30
"New To The Street" Announces Upcoming Interviews With 6 New Clients & 5 Recurring Clients
"New To The Street" Announces Upcoming Interviews With 6 New Clients & 5 Recurring Clients
Source: OTC Markets
Date: August, 24 2015 00:00

 


About CDEX Inc. (OTC: CDEX)

Logo for CDEX Inc. (OTC: CDEX)

About CDEX Inc. lt br / gt CDEX develops, manufactures and globally distributes products to the healthcare, safety and security markets. The ValiMed TM product line provides life saving validation of high risk medications and pharmacy returned narcotics. The ID TM product line detects trace amounts of illegal drugs, such as methamphetamine. CDEX expects to advance its patented technologies to serve additional markets in the future where its proprietary products can be launched. To learn more about CDEX please visit: www.cdex inc.com.

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $285,084 - 03/09/2018
  • Authorized: 300,000,000 - 02/03/2015
  • Issue and Outstanding: 81,452,520 - 06/15/2015
  • Float: 25,360,965 - 02/03/2015

 


Recent Filings from (OTC: CDEX)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: October, 26 2015
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: October, 19 2015
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: October, 06 2015
Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: September, 15 2015
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: September, 14 2015
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: June, 15 2015
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 01 2015

 

 


Daily Technical Chart for (OTC: CDEX)

Daily Technical Chart for (OTC: CDEX)


Stay tuned for daily updates and more on (OTC: CDEX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: CDEX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

Monsta Trader
@MonstaTrader

 

 


Disclaimer: Monsta Trader publishes reports providing information on selected companies. Monsta Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. Monsta Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CDEX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Monsta Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. Monsta Trader does not own any shares of CDEX and does not buy, sell, or trade any shares of CDEX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by Monsta Trader. All rights reserved. Our Full Disclaimer: http://monstatrader.com/disclaimer/